search
Back to results

Early Ambulation After Adductor Canal Block for Total Knee Arthroplasty

Primary Purpose

Pain, Osteoarthritis

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Canal Block and Capsular Injection
Femoral Nerve Block with Tibial Nerve Block
Sponsored by
Trinity Health Of New England
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pain focused on measuring early ambulation, knee arthroplasty

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • knee arthroplasty
  • ages 18-80

Exclusion Criteria:

  • history of neurological disease
  • diabetes
  • pregnancy
  • neuropathy
  • chronic narcotic use
  • allergy to local anesthetic solution or NSAIDS
  • inability to give consent or cooperate with the study protocol

Sites / Locations

  • Saint Francis Hospital and Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Canal Block and Capsular Injection

Femoral with Tibial Nerve Block

Arm Description

Adductor canal block with a continuous catheter and ultrasound guided posterior capsular injection with local anesthetic solution.

Continuous femoral nerve block with catheter and selective tibial nerve block in the popliteal fossa.

Outcomes

Primary Outcome Measures

Ability to ambulate post operatively.
Ability to ambulate and perform tasks of the rehabilitation program and reach rehabilitation milestones after total knee arthroplasty.

Secondary Outcome Measures

Pain scores at rest and with knee flexion.
Measures of pain score using numeric pain rating scale (0=no pain, 10=worst pain) completed by patient in recovery room and every 6 hours for a 72 hour period after discharge from recovery room.
Pain Medication Consumption
Amount of opioid consumption post surgery for 72 hours.

Full Information

First Posted
October 6, 2011
Last Updated
March 4, 2013
Sponsor
Trinity Health Of New England
search

1. Study Identification

Unique Protocol Identification Number
NCT01459861
Brief Title
Early Ambulation After Adductor Canal Block for Total Knee Arthroplasty
Official Title
Assessment of Early Ambulation in Patients Receiving Continuous Adductor Canal Block With Ultrasound Guided Posterior Capsular Knee Injection vs. Femoral Nerve Block With Tibial Nerve Block Following Total Knee Replacement
Study Type
Interventional

2. Study Status

Record Verification Date
February 2013
Overall Recruitment Status
Terminated
Why Stopped
Administratively closed early
Study Start Date
October 2011 (undefined)
Primary Completion Date
September 2012 (Actual)
Study Completion Date
September 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Trinity Health Of New England

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to assess early ambulation following total knee replacement in patients receiving continuous adductor canal block with posterior capsular injection compared to continuous femoral nerve block with tibial nerve block.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain, Osteoarthritis
Keywords
early ambulation, knee arthroplasty

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Care Provider
Allocation
Randomized
Enrollment
11 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Canal Block and Capsular Injection
Arm Type
Experimental
Arm Description
Adductor canal block with a continuous catheter and ultrasound guided posterior capsular injection with local anesthetic solution.
Arm Title
Femoral with Tibial Nerve Block
Arm Type
Active Comparator
Arm Description
Continuous femoral nerve block with catheter and selective tibial nerve block in the popliteal fossa.
Intervention Type
Procedure
Intervention Name(s)
Canal Block and Capsular Injection
Intervention Description
Continuous Adductor canal block with 15ml of ropivacaine 0.2% with epinephrine 1:400,000 followed by an infusion of ropivacaine 0.2% at 6ml per hour for 2 days post operatively. This is combined with ultrasound guided posterior capsular knee injection with 30ml ropivacaine 0.2% with epinephrine 1:400,000.
Intervention Type
Procedure
Intervention Name(s)
Femoral Nerve Block with Tibial Nerve Block
Intervention Description
Continuous femoral nerve block with 15ml of ropivacaine 0.2% followed by an infusion of ropivacaine 0.2% at 6ml per hour for 2 days after surgery combined with tibial nerve block in the popliteal fossa with ropivacaine 0.5% up to 15ml.
Primary Outcome Measure Information:
Title
Ability to ambulate post operatively.
Description
Ability to ambulate and perform tasks of the rehabilitation program and reach rehabilitation milestones after total knee arthroplasty.
Time Frame
Up to 3 days (72 hours) post surgery.
Secondary Outcome Measure Information:
Title
Pain scores at rest and with knee flexion.
Description
Measures of pain score using numeric pain rating scale (0=no pain, 10=worst pain) completed by patient in recovery room and every 6 hours for a 72 hour period after discharge from recovery room.
Time Frame
Up to 3 days ( 72 hours) after surgery
Title
Pain Medication Consumption
Description
Amount of opioid consumption post surgery for 72 hours.
Time Frame
Up to 3 days (72 hours) post surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: knee arthroplasty ages 18-80 Exclusion Criteria: history of neurological disease diabetes pregnancy neuropathy chronic narcotic use allergy to local anesthetic solution or NSAIDS inability to give consent or cooperate with the study protocol
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sanjay Sinha, M.D.
Organizational Affiliation
Saint Francis Memorial Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Saint Francis Hospital and Medical Center
City
Hartford
State/Province
Connecticut
ZIP/Postal Code
06105
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Early Ambulation After Adductor Canal Block for Total Knee Arthroplasty

We'll reach out to this number within 24 hrs